Talend S.A. ADR (TLND)

65.97  +0.01 (+0.02%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to TLND. TLND was compared to 284 industry peers in the Software industry. TLND has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, TLND is valued expensive at the moment.



Quickly go to:

0

1. Profitability

1.1 Basic Checks

TLND had negative earnings in the past year.

1.2 Ratios

Industry RankSector Rank
ROA -21.88%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM -24.4%
PM (TTM) -27.29%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

2

2. Health

2.1 Basic Checks

There is no outstanding debt for TLND. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

An Altman-Z score of 2.03 indicates that TLND is not a great score, but indicates only limited risk for bankruptcy at the moment.
TLND has a Debt/Equity ratio of -46.66. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity -46.66
Debt/FCF N/A
Altman-Z 2.03
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 1.27 indicates that TLND should not have too much problems paying its short term obligations.
A Quick Ratio of 1.27 indicates that TLND should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.27
Quick Ratio 1.27

More info and screens

5

3. Growth

3.1 Past

TLND shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.35%.
TLND shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 17.57%.
Measured over the past years, TLND shows a very strong growth in Revenue. The Revenue has been growing by 30.50% on average per year.
EPS 1Y (TTM)7.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)17.57%
Revenue growth 3Y24.6%
Revenue growth 5Y30.5%
Sales Q2Q%19.43%

3.2 Future

The Earnings Per Share is expected to grow by 15.83% on average over the next years. This is quite good.
Based on estimates for the next years, TLND will show a quite strong growth in Revenue. The Revenue will grow by 15.85% on average per year.
EPS Next Y-31.3%
EPS Next 2Y23.92%
EPS Next 3Y30.31%
EPS Next 5Y15.83%
Revenue Next Year15.82%
Revenue Next 2Y15.91%
Revenue Next 3Y16.14%
Revenue Next 5Y15.85%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

TLND reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for TLND. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -31.46

4.3 Compensation for Growth

A more expensive valuation may be justified as TLND's earnings are expected to grow with 30.31% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y23.92%
EPS Next 3Y30.31%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for TLND!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Talend S.A. ADR

NASDAQ:TLND (7/29/2021, 8:00:01 PM)

65.97

+0.01 (+0.02%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.16B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -21.88%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM -24.4%
PM (TTM) -27.29%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity -46.66
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.27
Quick Ratio 1.27
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)7.35%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y-31.3%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)17.57%
Revenue growth 3Y24.6%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y